DOCTORS'
Medical Case Studies
DOCTORS'
Medical Case Studies
Revlimid
Lenalidomide
Lenalidomide, initially known as CC-5013 and marketed as Revlimid by Celgene, is a derivative of thalidomide introduced in 2004. It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Lenalidomide has also shown efficacy in the class of hematological disorders known as myelodysplastic syndromes (MDS). Lenalidomide and bortezomib are considered therapeutic breakthroughs in the treatment of myeloma, which generally carries a poor prognosis.
Revlimid - List of case studies
- IgG Multiple Myeloma
-
extent, many of us now preferentially use lenalidomide (Revlimid), since it is somewhat more potent, less sedating, and not ... bortezomib, steroids, dexamethasone, lenalidomide, Revlimid, decadron (VRD), decadron (VTD), melphalan, Decadron, doxil, ... bortezomib, steroids, dexamethasone, lenalidomide, Revlimid, decadron (VRD), decadron (VTD), melphalan, Decadron, doxil, ...
- Drugs
-
Lederfolin Lenalidomide Lenalidomide (Revlimid) Lenalidomide (Revlimid) Lentokalium Lercanidipine Letrosole Leucovorin ...
- Pancytopenia of uncertain pathogenesis
-
syndrome then treatment options include the use of Revlimid which can be given especially if there is evidence for (5q) chromosome ... is poor , however, the newer treatments using Revlimid or Vidaza or Dacogen have been very helpful in improving quality of ...
- MDS – Myelodysplastic Syndrome
-
3) Occasional patients will respond to lenalidomide (Revlimid). This is particularly true if there is a chromosome 5 abnormality, ... Procrit, Aranesp, Epogen, G-CSF, Neupogen, lenalidomide, Revlimid, Vidaza, Dacogen, Azacitidine. Treatments : inhalations, ...
- PANCYTOPENIA OF UNKNOWN PATHOGENESIS
-
syndrome then treatment options include the use of Revlimid which can be given especially if there is evidence for (5q) ... syndrome, is poor, however, the newer treatments using Revlimid or Vidaza or Dacogen have been very helpful in improving quality ...
- Multiple myeloma with renal involvement, bone lesions and Neuropathy
-
can also be administered. Lenalidomide (Revlimid) , as a single agent, or better in a combination, usually with ... Ticlopidina, Lasix, Tavor, melphalan, Lenalidomide (Revlimid), doxorubicin (adriamycin), Doxil, VAD, cyclophosphamide, ...
- Multiple Myeloma (MM) and Cardiomyopathy
-
the bortezomib for later disease stages, or using revlimid (lenalidomide) with or without dexamthasone ( RevDex ) exist ... might help in reducing the risk of bleeding. o Revlimid (lenalidomide) , a relatively novel agent which is considered ...
- Myelodysplastic syndrome (MDS), with kariotype del(11)q(11)
-
3) Occasional patients will respond to lenalidomide (Revlimid) . This is particularly true if there is a chromosome 5 abnormality ... Aranesp, Epogen), G-CSF (Neupogen), lenalidomide (Revlimid), Vidaza, Dacogen, Azacitidine ...